戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 vation and lineage specification of resident cardiac stem cells.
2 nous regeneration via activation of resident cardiac stem cells.
3  properties have been demonstrated for human cardiac stem cells.
4 n(-) c-kit(POS) cells with the properties of cardiac stem cells.
5                                              Cardiac stem cells also express nucleostemin that is dim
6 ther with fundamental scientific advances in cardiac stem cell and regenerative biology, are beginnin
7                                              Cardiac stem cells and early committed cells (CSCs-ECCs)
8 erentiated myocytes, provides a link between cardiac stem cells and myocyte differentiation.
9 dissected in terms of the critical role that cardiac stem cells and myocyte regeneration play in the
10 rogenitors, mesenchymal stem cells, resident cardiac stem cells, and both mouse and human embryonic s
11 es and vasculature cells, recruit endogenous cardiac stem cells, and secrete a wide array of paracrin
12 mulation of A2B adenosine receptors on mouse cardiac stem cell antigen (Sca)-1(+)CD31(-) mesenchymal
13 en intravenously after ischemia/reperfusion, cardiac stem cell antigen 1 cells home to injured myocar
14 l approaches will capitalize upon the use of cardiac stem cells as therapeutic reagents.
15 egeneration by the infused MSC or endogenous cardiac stem cells based on lack of evidence for cardiac
16         In this Perspective, we consider how cardiac stem cell biology has led us into clinical trial
17 in the heart, c-kit is expressed not only by cardiac stem cells but also by cardiomyocytes, commencin
18 ency is attributable to the lack of resident cardiac stem cells, combined with roadblocks that limit
19 quired for stem cell activation, but whether cardiac stem cell (CSC) function is regulated by the hyp
20    Importantly, the consequences of aging on cardiac stem cell (CSC) growth and senescence were evalu
21 e tested whether the human heart possesses a cardiac stem cell (CSC) pool that promotes regeneration
22   We hypothesized that the growth reserve of cardiac stem cells (CSCs) and circulating cytokines prom
23 al of this study is to characterize resident cardiac stem cells (CSCs) and investigate their therapeu
24 he consequence of this neurohumoral burst on cardiac stem cells (CSCs) are unknown.
25 liferation and differentiation of endogenous cardiac stem cells (CSCs) as part of their regenerative
26                                              Cardiac stem cells (CSCs) delivered to the infarcted hea
27 neage, and overexpression of Pim1 in ckit(+) cardiac stem cells (CSCs) enhances their cardioreparativ
28                    Both cardiac myocytes and cardiac stem cells (CSCs) express the receptor of growth
29                                              Cardiac stem cells (CSCs) have been identified in the ad
30                               C-kit-positive cardiac stem cells (CSCs) have been shown to improve myo
31 ulatory angiogenic cells (CACs) and resident cardiac stem cells (CSCs) have both been shown to improv
32 d mesenchymal stem cells (MSCs) and c-kit(+) cardiac stem cells (CSCs) improve left ventricular remod
33             c-kit-positive, lineage-negative cardiac stem cells (CSCs) improve post-infarction left v
34 s vein-derived pericytes (SVPs) with that of cardiac stem cells (CSCs) in a model of myocardial infar
35 zed, open-label trial of autologous c-kit(+) cardiac stem cells (CSCs) in patients with heart failure
36 roliferation and differentiation of c-kit(+) cardiac stem cells (CSCs) in vivo and in vitro, we hypot
37        Identifying a bona fide population of cardiac stem cells (CSCs) is a critical step for develop
38 tus on the cardiac regenerative potential of cardiac stem cells (CSCs) is unknown yet critical, given
39                          Although c-kit(pos) cardiac stem cells (CSCs) preserve left ventricular (LV)
40                                        Human cardiac stem cells (CSCs) promote myocardial regeneratio
41 autologous mesenchymal stem cells (MSCs) and cardiac stem cells (CSCs) synergistically reduces scar s
42 ether the mouse heart at birth has a pool of cardiac stem cells (CSCs) that differentiate into myocyt
43 ate that HDAC inhibition stimulates c-kit(+) cardiac stem cells (CSCs) to facilitate myocardial repai
44                               The ability of cardiac stem cells (CSCs) to promote myocardial repair u
45 ed with an increase in the number of ckit(+) cardiac stem cells (CSCs).
46 hanistic and translational studies of c-kit+ cardiac stem cells (CSCs).
47                            Various routes of cardiac stem cell delivery have been reported, including
48 es seem to recover and do not elicit cKit(+) cardiac stem cell-derived myocyte regeneration.
49 tly linked to cardiomyogenesis and embryonic cardiac stem cell development and differentiation but ne
50 tify novel functions for c-kit: promotion of cardiac stem cell differentiation and regulation of card
51 d in cardiac hypertrophy, heart development, cardiac stem cell differentiation, and arrhythmias throu
52 r secreted proteins and membranes as genuine cardiac stem cells do.
53 positive (c-Kit(+)), CD45-negative (CD45(-)) cardiac stem cells (eCSCs) from whole adult mouse and ra
54 ult myocardium harbors endogenous c-kit(pos) cardiac stem cells (eCSCs), whose relevance for regenera
55 ence of a novel population of resident adult cardiac stem cells expressing PW1(+) and their involveme
56                Ex vivo expansion of resident cardiac stem cells, followed by delivery to the heart, m
57 the past two decades, several populations of cardiac stem cells have been described in the adult mamm
58 e of these properties, bone marrow cells and cardiac stem cells have been employed experimentally in
59                      More recently, resident cardiac stem cells have been shown to differentiate into
60                            Division of human cardiac stem cells (hCSCs) by nonrandom and random segre
61 tracoronary delivery of c-kit-positive human cardiac stem cells (hCSCs) is a promising approach to re
62 A progressive loss of telomeric DNA in human cardiac stem cells (hCSCs) occurs with aging and the new
63                The characterization of human cardiac stem cells (hCSCs) would have important clinical
64  benefits are unknown specifically for human cardiac stem cells (hCSCs).
65                                        Human cardiac stem cells (hCSCs, n = 10), hckit(+) CSCs overex
66 nd the challenges of clinical translation of cardiac stem cell imaging in the future.
67 f intracoronary delivery of allogeneic human cardiac stem cell in 55 patients with large acute myocar
68 a novel experience in humans with allogeneic cardiac stem cell in a rigorously imaging-based selected
69  a promising preclinical background, CAREMI (Cardiac Stem Cells in Patients With Acute Myocardial Inf
70 beat, and the possibility of a population of cardiac stem cells in the adult heart.
71 different populations of embryonic and adult cardiac stem cells, including KIT(+), PDGFRalpha(+), ISL
72   Overexpression of nucleostemin in cultured cardiac stem cells increases proliferation while preserv
73                           Establish a robust cardiac stem cell isolation and culture protocol to cons
74                  However, the discovery that cardiac stem cells live in the heart and differentiate i
75 othelial, and mesenchymal lineages, putative cardiac stem cell markers, and, interestingly, cardiomyo
76 as thought to be impossible, but multipotent cardiac stem cells may be able to renew the myocardium a
77 diac regeneration was via endogenous cKit(+) cardiac stem cell-mediated new myocyte formation.
78     We report that the dog heart possesses a cardiac stem cell pool characterized by undifferentiated
79        METHODS AND Isolation of 3 endogenous cardiac stem cell populations was performed from human h
80       Objective: To describe the progress in cardiac stem cell regenerative therapy using adult stem
81                                              Cardiac stem cells regulate myocyte turnover and conditi
82 development, congenital cardiac disease, and cardiac stem cell research.
83 e clusters strongly support the existence of cardiac stem cells that amplify and commit to the myocyt
84 ell compartment characterized by multipotent cardiac stem cells that possess the ability to acquire t
85                               The success of cardiac stem cell therapies is limited by low cell reten
86 , two causes of low survivability in current cardiac stem cell therapies, mechanical and metabolic, w
87                                              Cardiac stem cell therapy has shown very promising poten
88                       So far, candidates for cardiac stem cell therapy have been limited to patients
89 augmentation of cardiac functions similar to cardiac stem cell therapy.
90  recent debates-the contribution of c-Kit(+) cardiac stem cells to cardiomyocytes in the heart and th

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。